miR-324 expression was associated with tumor size in luminal B HER2-negative tumors. Upregulation of miR-324 was associated with age <50 and HER2 + status in ER+ and/or PR+ tumors with low Ki-67. This evidence concerns the gene ERBB2 and neoplasm.